Stuart Cobb
Chief Scientific Officer at Neurogene Inc. (NGNE) since December 2023
Stuart Cobb has filed 6 insider reports with the SEC since December 2023, as chief Scientific Officer at Neurogene Inc. (NGNE). In the last 12 months Stuart Cobb sold $141K of stock on the open market. In the latest filing, on March 17, 2026, Stuart Cobb sold 6,797 shares of Neurogene Inc. (NGNE) for $141K at an average of $20.81.
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $244K
Companies where Stuart Cobb is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officersince December 2023 | 30,497 | $244K | $22.15 | Mar 17, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 13, 2026-$141KNGNEChief Scientific Officer Cobb Stuart sold $141,446 worth of shares (6,797 units at $20.81), decreasing direct ownership by 18% to 30,497 unitsForm 4Open-market sale10b5-1 plan
- Feb 20, 2026NGNEChief Scientific Officer Cobb Stuart was granted 16,500 shares, increasing direct ownership by 79% to 37,294 unitsForm 4Grant or award
- May 14, 2025-$103KNGNEChief Scientific Officer Cobb Stuart sold $103,003 worth of shares (6,797 units at $15.15), decreasing direct ownership by 25% to 20,794 unitsForm 4Open-market sale10b5-1 plan
- Mar 26, 2025NGNEChief Scientific Officer Cobb Stuart was granted 7,200 shares, increasing direct ownership by 35% to 27,591 unitsForm 4Grant or award
- Mar 13, 2024NGNECobb Stuart was granted 20,391 sharesForm 4Grant or award
- Dec 18, 2023NGNEStuart Cobb became an insiderForm 3New insider
Compare Stuart Cobb with
- Stuart Cobb vs Rachel McMinn1 shared
- Stuart Cobb vs Christine Mikail Cvijic1 shared
- Stuart Cobb vs Keith Woods1 shared
- Stuart Cobb vs Christina Shafer1 shared
- Stuart Cobb vs Julie Jordan1 shared
- Stuart Cobb vs Rohan Palekar1 shared
Other insiders at the same companies
- Rachel McMinnNGNE
- Christine Mikail CvijicNGNE
- Keith WoodsNGNE
- Christina ShaferNGNE
- Julie JordanNGNE
- Rohan PalekarNGNE
- Robert BaffiNGNE
- Sarah B. NoonbergNGNE
- Cory S. FreedlandNGNE
- Robert Keith WoodsNGNE
- Samsara BioCapital GP, LLCNGNE
Questions about Stuart Cobb
- What is Stuart Cobb's role at Neurogene Inc.?
- Stuart Cobb reports to the SEC as chief Scientific Officer at Neurogene Inc. (NGNE), according to the latest filing on March 17, 2026.
- How many shares does Stuart Cobb own?
- After the latest filing that states it, Stuart Cobb directly owned 30,497 shares of Neurogene Inc. (NGNE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Stuart Cobb bought or sold stock recently?
- The most recent open-market sale was on March 13, 2026: sold 6,797 shares of Neurogene Inc. (NGNE) for $141K at an average of $20.81.
- How do I get alerts when Stuart Cobb files?
- Follow Stuart Cobb on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Stuart Cobb (SEC CIK 0001994301). Totals count each trade once, skipping amendments whose original is on file, from Dec 26, 2023 on. View on SEC EDGAR · Get this as JSON